Background & Mechanism of Action

Semax acetate is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH) fragment 4–7, with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Unlike the parent ACTH peptide, Semax lacks corticotropic activity and does not significantly stimulate the adrenal cortex, making it suitable for isolated investigation of central nervous system effects.

Research suggests that Semax may influence neurotrophic factor expression, including brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), and may modulate dopaminergic and serotonergic pathways. These properties have made it a subject of interest in in vitro models of neuroprotection, cognitive enhancement, and stress response. Researchers should note that the precise receptor-level mechanism of Semax remains an active area of investigation and results may vary by cell type and experimental model.

Materials & Equipment

• Semax acetate (SKU S1431098, Aladdin Scientific)
• Sterile ultrapure water or phosphate-buffered saline (PBS, pH 7.4)
• Analytical balance (0.01 mg readability)
• Low-protein-binding microcentrifuge tubes (1.5 mL)
• Sterile 0.22 µm syringe filters
• Micropipettes and sterile tips
• Vortex mixer
• –20 °C freezer (desiccated storage)
• Cell culture medium appropriate to experimental model
• Biosafety cabinet (for sterile work)

All equipment should be calibrated and certified for use with biological samples. Wear appropriate PPE including gloves, lab coat, and eye protection throughout.

Step-by-Step Protocol

Step 1 – Preparation of Stock Solution

Allow the vial of Semax acetate to equilibrate to room temperature inside its sealed container before opening, to prevent moisture condensation on the powder. In a biosafety cabinet, add the appropriate volume of sterile water or PBS (pH 7.4) to prepare a stock solution at a concentration of 1–10 mM. Gently vortex for 30–60 seconds until the peptide is fully dissolved. If the solution appears turbid, pass it through a 0.22 µm sterile syringe filter.

Step 2 – Aliquoting & Storage

Divide the stock solution into single-use aliquots in low-protein-binding microcentrifuge tubes. Label each tube with the compound name, lot number, concentration, date, and preparer initials. Store aliquots at –20 °C in a desiccated environment, protected from light. Avoid repeated freeze-thaw cycles, which may degrade peptide integrity. For short-term use (≤1 week), aliquots may be stored at 4 °C.

Step 3 – Preparation of Working Solutions

Thaw a single aliquot at room temperature immediately before use. Dilute the stock solution in pre-warmed cell culture medium to achieve the desired working concentration. Prepare working solutions fresh for each experiment. Working concentrations should be determined empirically based on the specific cell model and assay endpoint; consult published literature for guidance on concentration ranges relevant to your system.

Step 4 – Cell Treatment

Remove existing medium from cultured cells and replace with medium containing Semax acetate at the target working concentration. Include vehicle controls (medium without Semax acetate but with equivalent solvent volume) in every experiment. Incubate cells under standard culture conditions (e.g., 37 °C, 5% CO₂) for the duration determined by your experimental protocol. At the end of the incubation, proceed immediately to downstream assays (e.g., viability, gene expression, protein quantification).

Step 5 – Data Collection & Analysis

Process samples according to validated downstream assay protocols. Normalise results to vehicle-treated controls. Confirm linearity of detection and validate any novel application with appropriate positive controls. Record all observations in a laboratory notebook in compliance with your institution's good laboratory practice (GLP) guidelines.

Troubleshooting & Tips

Poor solubility: Ensure the solvent is sterile ultrapure water or PBS at neutral pH. Warming the solvent slightly (to ~37 °C) may improve dissolution. Avoid organic solvents unless compatibility with downstream assays has been confirmed.

Inconsistent results between experiments: Use single-use aliquots to avoid freeze-thaw degradation. Confirm that stock concentration is accurate by measuring absorbance (if applicable) or by amino acid analysis.

Cytotoxicity at high concentrations: Titrate the working concentration carefully. If cytotoxicity is observed, reduce the concentration and verify with a dose-response experiment. Always include a viability assay (e.g., MTT or trypan blue exclusion) alongside primary endpoints.

Contamination: Perform all reconstitution steps in a certified biosafety cabinet using aseptic technique. Filter-sterilise all solutions through a 0.22 µm membrane before adding to cell cultures.